Pase 2 mg Tablet is a benzodiazepine medicine from Opsonin Pharma Limited that contains clonazepam. It is used in the treatment of panic disorder and, alone or as an adjunct, in the treatment of seizure disorders.
There are 69 brands of Clonazepam listed in Bangladesh. 15 of them have a lower unit price than Pase. The lowest listed price is Clonazepam 2 mg Tablet at ৳ 6 per unit.
What is Pase 2 mg Tablet?
Pase 2 mg Tablet contains clonazepam, a benzodiazepine that acts on the nervous system. It has anticonvulsive, sedative, muscle-relaxing and anxiety-reducing effects. The medicine is prescribed for panic disorder, with or without agoraphobia, and for seizure disorders either alone or alongside other treatment. Because it can cause drowsiness and other central nervous system effects, it is meant to be taken under medical supervision. The doctor sets the dose and the length of the course for each person. Pase is available as tablets in a 4 x 15 pack.
Uses of Pase
Pase 2 mg Tablet is used to treat panic disorder, which involves unexpected panic attacks and the worry that more attacks may follow. It is also used for seizure disorders, either on its own or as an add-on to other anticonvulsant medicines. Clonazepam belongs to the benzodiazepine group and works by reducing excessive nerve activity. Only a registered doctor can decide whether it suits a particular person.
How to use Pase
Take Pase 2 mg Tablet exactly as the doctor instructs. The doctor decides the dose, how often to take it and how long the course should last, so follow the prescription rather than any general routine. Swallow the tablet with water. Do not stop treatment suddenly on your own, because stopping a benzodiazepine abruptly can cause problems; ask the doctor how to come off it. If you miss a dose, ask your pharmacist or doctor what to do.
Side effects of Pase
Drowsiness is the most frequent effect of clonazepam, and unsteadiness or poor coordination can also occur; these may lessen over time in some people. Behaviour changes have been reported. Other possible effects include abnormal eye movements, tremor, dizziness, confusion, low mood, memory problems, hallucinations, restlessness, sleep problems, a fast heartbeat and loss of voice. Tell your doctor if any effect troubles you or does not settle.
Safety and precautions
Do not use Pase 2 mg Tablet if you have had an allergic reaction to benzodiazepines, or if you have significant liver disease. It is not for acute narrow-angle glaucoma; people with open-angle glaucoma should only use it while receiving appropriate therapy. The doctor should be told about pregnancy, planned pregnancy or breastfeeding before use, and about any other medicines you take. People with several types of seizure disorder, or those taking valproic acid, need close medical review. Ask the doctor first if you have breathing problems or are elderly.
Frequently asked questions
How much does Pase 2 mg Tablet cost?
The listed price is ৳ 11.5. Ask your pharmacist about the current price at your local pharmacy, as it may differ between outlets.
Who should avoid Pase 2 mg Tablet or ask the doctor first?
People with a benzodiazepine allergy or significant liver disease should not use it, and it is contraindicated in acute narrow-angle glaucoma. Ask the doctor first if you are pregnant or breastfeeding, have breathing problems, or take other medicines, including valproic acid.
What is Pase 2 mg Tablet used for and what kind of medicine is it?
It is a benzodiazepine containing clonazepam. It is used for panic disorder and for seizure disorders, either alone or as an adjunct to other anticonvulsants. The doctor decides the dose and course.
How should Pase 2 mg Tablet be stored?
Keep it in a dry place away from light and heat, and out of the reach of children. Follow any additional storage instructions from your pharmacist.
It is indicated for the treatment of panic disorder, with or without agoraphobia. Panic disorder is characterized by the occurrence of unexpected panic attacks and associated concern about having additional attacks, worry about the implications or consequences of the attacks.
It is also indicated ... Read moreIt is indicated for the treatment of panic disorder, with or without agoraphobia. Panic disorder is characterized by the occurrence of unexpected panic attacks and associated concern about having additional attacks, worry about the implications or consequences of the attacks.
It is also indicated alone or as an adjunct in the treatment of the Lennox-Gastaut Syndrome (petit mal variant), akinetic and myoclonic seizures. It may be indicated in patients with absence seizures (petit mal) who have failed to respond to succinimides.
The effectiveness of Clonazepam in long-term use, that is, for more than 9 weeks, has not been systematically studied in controlled clinical trials. The physician who elects to use Clonazepam for extended periods should periodically reevaluate the long-term usefulness of the drug for the individual patient.
Pharmacology
Clonazepam exhibits pharmacological properties which are common to benzodiazepines and include anticonvulsive, sedative, muscle relaxing and anxiolytic effects. The central actions of benzodiazepines are mediated through an enhancement of the GABAergic neurotransmission at inhibitory synapses. In the presence of benzodiazepines the affinity of the GABA receptor for the neurotransmitter is enhanced through positive allosteric modulation resulting in an increased action of released GABA on the postsynaptic transmembrane chloride ion flux.
There are also animal data showing an effect of clonazepam on serotonin. Animal data and electroencephalographic investigations in man have shown that clonazepam rapidly suppresses many types of paroxysmal activity including the spike and wave discharge in absences seizures (petit mal), slow spike wave, generalized spike wave, spikes with temporal or other locations as well as irregular spikes and waves. Generalized EEG abnormalities are more regularly suppressed than focal abnormalities. According to these findings clonazepam has beneficial effects in generalized and focal epilepsies.
Dosage & Administration
Oral:
Adults: The initial dose for adults with seizure disorders should not exceed 1.5 mg/day divided into three doses. Dosage may be increased in increments of 0.5 to 1 mg every 3 days until seizures are adequately controlled or until side effects preclude any further increase. Maintenance dosage must be individualized for each patient depending upon response. Maximum recommended daily dose is 20 mg.
The initial dose for adults with panic disorder is 0.25 mg given in two divided dose. An increase to the target dose for most patients of 1 mg/day may be made after 3 days.
Pediatric Patients: In order to minimize drowsiness, the initial dose for infants and children (up to 10 years of age or 30 kg of body weight) should be between 0.01 and 0.03 mg/kg/day but not to exceed 0.05 mg/kg/day given in two or three divided doses.
Injection:
Infants and children: half of a vial (0.5 mg) by slow IV injection or by IV infusion.
Adults: 1 vial (1 mg) by slow IV injection or by IV infusion. This dose can be repeated as required (1-4 mg are usually sufficient to reverse the status). In adults, the rate of injection must not exceed 0.25 - 0.5 mg per minute (0.5-1.0 ml of the prepared solution) and a total dose of 10 mg should not be exceeded.
Interaction
Clonazepam does not appear to alter the pharmacokinetics of phenytoin, carbamazepine or phenobarbital. The effect of Clonazepam on the metabolism of other drugs has not been investigated.
Contraindications
It should not be used in patients with a history of hypersensitivity to benzodiazepines, nor in patients with clinical or biochemical evidence of significant liver disease. It may be used in patients with open angle glaucoma who are receiving appropriate therapy but is contraindicated in acute narrow angle glaucoma.
Side Effects
The most frequently occurring side effects of Clonazepam are referable to CNS depression. Experience in treatment of seizures has shown that drowsiness has occurred in approximately 50% of patients and ataxia in approximately 30%. In some cases, these may diminish with time; behavior problems have been noted in approximately 25% of patients. Abnormal eye movements, aphonia, coma, tremor, vertigo, confusion, depression, amnesia, hallucinations, hysteria, increased libido, insomnia, psychosis & palpitations may also occur.
Pregnancy & Lactation
Pregnancy: From preclinical studies it cannot be excluded that clonazepam possesses the possibility of producing congenital malformations. From epidemiological evaluations there is evidence that anticonvulsant drugs act as teratogens. However, it is difficult to determine from published epidemiological reports which drug or combination of drugs is responsible for defects in the newborn. The possibility also exists that other factors e.g. genetic factors or the epileptic condition itself may be more important than drug therapy in leading to birth defects. Under these circumstances, the drug should only be administered to pregnant women if the potential benefits outweigh the risk to the foetus. During pregnancy, Clonazepam may be administered only if there is a compelling indication. Administration of high doses in the last trimester of pregnancy or during labour can cause irregularities in the heartbeat of the unborn child and hypothermia, hypotonia, mild respiratory depression and poor feeding in the neonate. It should be borne in mind that both pregnancy itself and abrupt discontinuation of the medication can cause exacerbation of epilepsy. Withdrawal symptoms in newborn infants have occasionally been reported with benzodiazepines.
Nursing Mothers: Although the active ingredient of Clonazepam has been found to pass into the maternal milk in small amounts only, mothers undergoing treatment with this drug should not breastfeed. If there is a compelling indication for Clonazepam, breastfeeding should be discontinued.
Precautions & Warnings
When used in patients in whom several different types of seizure disorders coexist, Clonazepam may increase the incidence or precipitate the onset of generalized tonic-clonic seizures. This may require the addition of appropriate anticonvulsants or an increase in their dosages. The concomitant use of valproic acid and Clonazepam may produce absence status.
Overdose Effects
Symptoms: Benzodiazepines commonly cause drowsiness, ataxia, dysarthria and nystagmus. Overdose of Clonazepam is seldom life-threatening if the drug is taken alone, but may lead to areflexia, apnoea, hypotension, cardiorespiratory depression and coma. Coma, if it occurs, usually lasts a few hours but it may be more protracted and cyclical, particularly in elderly patients. Increased frequency of seizures may occur in patients at supratherapeutic plasma concentrations. Benzodiazepine respiratory depressant effects are more serious in patients with respiratory disease. Benzodiazepines increase the effects of other central nervous system depressants, including alcohol.
Treatment: Monitor the patient’s vital signs and institute supportive measures as indicated by the patient’s clinical state. In particular, patients may require symptomatic treatment for cardiorespiratory effects or central nervous system effects. Further absorption should be prevented using an appropriate method e.g. treatment within 1-2 hours with activated charcoal. If activated charcoal is used airway protection is imperative for drowsy patients. In case of mixed ingestion gastric lavage may be considered, however not as a routine measure. If CNS depression is severe consider the use of flumazenil, a benzodiazepine antagonist. This should only be administered under closely monitored conditions. It has a short half-life (about an hour), therefore patients administered flumazenil will require monitoring after its effects have worn off. Flumazenil is to be used with extreme caution in the presence of drugs that reduce seizure threshold (e.g. tricyclic antidepressants). Refer to the prescribing information for flumazenil, for further information on the correct use of this drug.
Storage Conditions
Keep in a dry place away from light and heat. Keep out of the reach of children.
Alternative brands of Clonazepam
Other brands with the same generic name, cheapest first.